Machine-learning clustering analysis identifies novel phenogroups in patients with ST-elevation acute myocardial

Andrija Matetic1, Theocharis Kyriacou2, Mamas A Mamas3

  • 1Department of Cardiology, University Hospital of Split, Split, Croatia; Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, United Kingdom.

Insights

Machine learning identified four patient clusters for ST-elevation myocardial infarction (STEMI), revealing distinct risk profiles and outcomes. The "diabetes with end-organ damage" cluster showed the worst prognosis, while the "behavioral risk" cluster had the best outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Artificial Intelligence in Healthcare
  • Health Informatics

Background:

  • Machine learning clustering can stratify patients with ST-elevation acute myocardial infarction (STEMI).
  • Understanding patient subgroups is crucial for optimizing risk assessment, management strategies, and predicting prognosis in STEMI.
  • Previous studies have not fully elucidated distinct phenogroups within the STEMI population using data-driven approaches.

Purpose of the Study:

  • To apply machine learning clustering to identify distinct patient subgroups within STEMI.
  • To compare the risk profiles, clinical outcomes, and management patterns across identified STEMI clusters.
  • To investigate the prognostic implications of these data-driven phenogroups.

Main Methods:

  • Utilized the National Inpatient Sample database (October 2015-December 2019) for adult STEMI discharges, excluding prior myocardial infarction cases.
  • Employed machine-learning clustering based on 21 clinical attributes to define patient subgroups.
  • Performed multivariable logistic regression to compare outcomes and management across clusters, calculating adjusted odds ratios (aOR) and 95% confidence intervals (95% CI).

Main Results:

  • Identified four distinct STEMI clusters from 470,960 cases: 'behavioural risk' (n=205,640), 'least comorbidity' (n=146,400), 'diabetes with end-organ damage' (n=45,100), and 'cardiometabolic' (n=73,820).
  • Hypertension and diabetes were the most significant attributes for clustering.
  • The 'diabetes with end-organ damage' cluster had the highest mortality, MACCE, and ischemic stroke rates, with the lowest invasive management utilization (p < 0.001).
  • The 'behavioural risk' cluster demonstrated the best in-hospital prognosis and highest invasive management rates (p < 0.001).

Conclusions:

  • Machine learning effectively identifies distinct patient subgroups in STEMI, characterized by unique prevalence, risk profiles, prognoses, and management patterns.
  • These data-driven phenogroups highlight significant variations in outcomes and treatment utilization among STEMI patients.
  • Further research into these high-risk phenogroups is warranted to refine clinical decision-making and improve patient care.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
496
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500